SE447262B - Analogiforfarande for framstellning av en undekapeptid med immunopotentierande egenskaper - Google Patents

Analogiforfarande for framstellning av en undekapeptid med immunopotentierande egenskaper

Info

Publication number
SE447262B
SE447262B SE7804612A SE7804612A SE447262B SE 447262 B SE447262 B SE 447262B SE 7804612 A SE7804612 A SE 7804612A SE 7804612 A SE7804612 A SE 7804612A SE 447262 B SE447262 B SE 447262B
Authority
SE
Sweden
Prior art keywords
glu
obzl
boc
lys
val
Prior art date
Application number
SE7804612A
Other languages
English (en)
Swedish (sv)
Other versions
SE7804612L (sv
Inventor
S-S Wang
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/871,563 external-priority patent/US4116951A/en
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of SE7804612L publication Critical patent/SE7804612L/xx
Publication of SE447262B publication Critical patent/SE447262B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06086—Dipeptides with the first amino acid being basic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/57581—Thymosin; Related peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
    • C07K5/06043—Leu-amino acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
SE7804612A 1977-04-22 1978-04-21 Analogiforfarande for framstellning av en undekapeptid med immunopotentierande egenskaper SE447262B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US78989877A 1977-04-22 1977-04-22
US05/871,563 US4116951A (en) 1977-04-22 1978-01-23 [Asn2 ]-thymosin α1 and analogs thereof

Publications (2)

Publication Number Publication Date
SE7804612L SE7804612L (sv) 1978-12-20
SE447262B true SE447262B (sv) 1986-11-03

Family

ID=27120967

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7804612A SE447262B (sv) 1977-04-22 1978-04-21 Analogiforfarande for framstellning av en undekapeptid med immunopotentierande egenskaper

Country Status (18)

Country Link
JP (1) JPS53137914A (da)
AT (1) AT364470B (da)
CA (1) CA1113088A (da)
CH (3) CH641152A5 (da)
DE (1) DE2817082A1 (da)
DK (1) DK147918C (da)
ES (1) ES469016A1 (da)
FI (1) FI781241A (da)
FR (2) FR2401134A1 (da)
GB (1) GB1590668A (da)
GR (1) GR71886B (da)
HU (1) HU180783B (da)
IT (1) IT1113134B (da)
LU (1) LU79488A1 (da)
NL (1) NL7804364A (da)
NO (2) NO781404L (da)
PT (1) PT67937B (da)
SE (1) SE447262B (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4116951A (en) * 1977-04-22 1978-09-26 Hoffmann-La Roche Inc. [Asn2 ]-thymosin α1 and analogs thereof
DE2919592A1 (de) * 1979-05-15 1981-01-15 Max Planck Gesellschaft Verfahren zur herstellung von thymosin- alpha 1 und derivaten davon
EP0033384B1 (de) * 1980-01-18 1984-02-15 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Thymosin-alpha-1-Fragmente enthaltende Arzneimittel mit immunstimulierender Wirkung, und Thymosin-alpha-1-Fragmente
US4339427A (en) * 1980-04-14 1982-07-13 Hoffmann-La Roche Inc. Radioimmunoassay of thymosinα
EP0056594B1 (de) * 1981-01-14 1984-09-12 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Thymosin-alpha-1-Fragmente enthaltende Arzneimittel mit immunregulierender Wirkung und Thymosin-alpha-1-Fragmente
CN1058500C (zh) * 1993-02-03 2000-11-15 施塞克龙药品公司 胸腺素α－1衍生物
US6262230B1 (en) * 1994-01-28 2001-07-17 Sciclone Pharmaceuticals Inc. Analogs of thymosin α1

Also Published As

Publication number Publication date
FR2401134B1 (da) 1983-09-30
DE2817082A1 (de) 1978-11-02
FI781241A (fi) 1978-10-23
FR2405926A1 (fr) 1979-05-11
DK169478A (da) 1978-10-23
GB1590668A (en) 1981-06-03
PT67937A (en) 1978-05-01
FR2405926B1 (da) 1983-09-09
NO148924B (no) 1983-10-03
SE7804612L (sv) 1978-12-20
NL7804364A (nl) 1978-10-24
PT67937B (en) 1980-04-07
IT1113134B (it) 1986-01-20
LU79488A1 (de) 1979-05-25
DK147918B (da) 1985-01-07
HU180783B (en) 1983-04-29
CH641152A5 (en) 1984-02-15
CH641153A5 (en) 1984-02-15
FR2401134A1 (fr) 1979-03-23
JPS53137914A (en) 1978-12-01
GR71886B (da) 1983-08-04
NO148924C (no) 1984-01-11
DK147918C (da) 1985-08-19
AT364470B (de) 1981-10-27
CH640218A5 (en) 1983-12-30
NO781404L (no) 1978-10-24
ATA286178A (de) 1981-03-15
IT7822629A0 (it) 1978-04-21
NO821608L (no) 1978-10-24
ES469016A1 (es) 1980-01-01
CA1113088A (en) 1981-11-24

Similar Documents

Publication Publication Date Title
JPS6328440B2 (da)
AU633872B2 (en) Glycine derivatives
DE69002448T2 (de) Zyklische Pentapeptide als Endothelin-Antagonisten.
EP1006122B1 (en) Phenethylamine derivatives
EP0221019B1 (en) Peptides
JPH01125398A (ja) アミノ酸誘導体およびその製法
JP3003252B2 (ja) ヒダントイン誘導体
EP0026464A2 (de) Peptide, deren Herstellung, deren Verwendung und pharmazeutische Präparate
SE447389B (sv) Nya tripeptider, som inverkar pa det centrala nervsystemet
CA1251898A (en) Pharmaceutical peptides, their preparation and use
CA1267996A (en) Peptides which are active on the central nervous system and have an action on the cholinergic system
SE447262B (sv) Analogiforfarande for framstellning av en undekapeptid med immunopotentierande egenskaper
EP0081838B1 (en) Cyclohexyl and phenyl substituted enkephalins
DE2740699C2 (da)
CH636598A5 (de) Verfahren zur herstellung neuer psychopharmakologisch aktiver peptide.
US3856770A (en) Psychopharmacologically active tetra-, penta-, hexa-, and heptapeptides
JPH0745460B2 (ja) 新規なスパガリン関連化合物およびその製造法
DE69426897T2 (de) Antithrombotisch wirkende azacycloalkyl-alkanoyl-peptide und-pseudopeptide
US4124703A (en) Luliberin analogs
US3801561A (en) Derivatives of salmon thyrocalcitonin
EP0085963B1 (en) Pharmaceutical compounds, preparation, use and intermediates therefor and their preparation
GB1587427A (en) Polypeptide derivatives
US4238390A (en) Synthesis and biological activity of [D-Thr2, Δ3 Pro5 ]-enkephalinamide
US3272790A (en) Polypeptides
CA1131217A (en) Psycho-pharmacological peptides

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7804612-5

Effective date: 19900411

Format of ref document f/p: F